BUSINESS
Nihon Chouzai to Go Private through Tender Offer Backed by Advantage Partners
Major Japanese pharmacy chain Nihon Chouzai has endorsed a tender offer led by Tokyo-based private equity fund Advantage Partners (AP) and recommended shareholder participation, paving the way for delisting from the Tokyo Stock Exchange. Nihon Chouzai said on July 31…
To read the full story
Related Article
- Nihon Chouzai Tender Offer Completed, Set to Delist under Advantage Partners
September 18, 2025
BUSINESS
- Teikoku to Market Medipost’s Knee OA Cell Therapy in Japan
December 22, 2025
- Clinigen Japan Adds 4 Products, Including Takeda’s Buccolam
December 22, 2025
- Meiji Backs US Incubator MBC BioLabs to Boost Open Innovation
December 22, 2025
- Boehringer Passes on Option for Nxera’s Schizophrenia Program
December 22, 2025
- Otsuka Kicks Off Global PIII of Phenylketonuria Drug
December 22, 2025
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…





